comparemela.com

Latest Breaking News On - Ray gordon - Page 18 : comparemela.com

Horizon Therapeutics plc to Highlight Data and Education on Thyroid Eye Disease (TED) at the Endocrine Society (ENDO) 2022 Annual Conference

Poster presentation will share results from the Phase 2 and Phase 3 trials on blood glucose levels in patients with Thyroid Eye Disease (TED) Three-time Olympic gold medalist Gail Devers will

United statesTina venturaGail deversTerryj smithRay gordonRachel vannProduct communicationsKellogg eye centerCommunications centerEndocrine society annual conferenceEuropean group on grave orbitopathyUniversity of michigan medical schoolThyroid eye diseaseEndocrine societyAnnual conferenceThyroid eye disease patients

Horizon Therapeutics plc Wins 2022 International CSR Excellence Award for RAREis Adoption Fund

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the company has won an International Corporate Social Responsibility (CSR) Excellence Award for its partnership with Gift of Adoption to co-create

United statesTim walbertCatherine riedelMichelle rivasRareis instagramRay gordonProduct communicationsGreen organisationRareis adoption fundInternational corporate social responsibilityHorizon therapeuticsExcellence awardAdoption fundCorporate visibility media relations

Horizon Therapeutics plc: Analysis from the Phase 3 N-MOmentum Study Demonstrates the Effectiveness of UPLIZNA (inebilizumab-cdon) Among Neuromyelitis Optica Spectrum Disorder Patients with Genetic Variations

Data being presented at the CMSC Annual Meeting demonstrates UPLIZNA may reduce attack risk and disability among populations with genetic variables typically linked to poor treatment response

United statesKristina pattersonNeuromyelitis opticaBruce creeRay gordonNeuroimmunol neuroinflammAyala mdelTina venturaGarrido edeRachel vannProduct communicationsDj associationExchange commissionConsortium of multiple sclerosis centersMultiple sclerosis centersAnnual meeting

Horizon Therapeutics plc to Present MIRROR Randomized Controlled Trial Primary Endpoint Data at The EULAR 2022 European Congress of Rheumatology

Oral presentation on KRYSTEXXA (pegloticase injection) plus methotrexate to be held June 2, 2022 at 11:35 a.m. CEST Additional data presentations provide new insights on psychosocial and

United statesAmanda phranerTheresa podrebaracTina venturaBrian lamoreauxRay gordonErin linnihanJohn botsonEuropean congressProduct communicationsExchange commissionA national perspectiveDouble blindPlacebo controlledMulticenter studyMethotrexate combined

Horizon Therapeutics plc Announces Dara Mann as a Healthcare Businesswomen s Association 2022 Rising Star

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that Dara Mann, vice president, marketing, ophthalmology, has been named a 2022 Healthcare Businesswomen's Association (HBA) Rising Star. Mann

Keli walbertDara mannCatherine riedelRay gordonHealthcare businesswomen associationHealthcare businesswomen association rising starHorizon therapeuticsHealthcare businesswomenAssociation rising starCorporate visibilityMedia contact

vimarsana © 2020. All Rights Reserved.